Is Ginger Good for Fatty Liver?

Ginger is increasingly discussed as a natural aid for liver health, but is ginger good for fatty liver disease? Fatty liver disease, particularly metabolic dysfunction-associated steatotic liver disease (MASLD), affects up to one in three adults in the UK and is closely linked to obesity, insulin resistance and poor diet. Ginger contains active compounds such as gingerols and shogaols with anti-inflammatory and antioxidant properties that may support liver health. This article examines the current evidence, safe consumption levels and how ginger fits within a broader, clinician-guided approach to managing fatty liver disease.

What is fatty liver disease and how common is it in the UK?

Fatty liver disease, particularly MASLD, affects up to one in three UK adults and is linked to obesity, type 2 diabetes and insulin resistance. Early stages are often symptom-free, making routine monitoring and lifestyle intervention essential.

Fatty liver disease is a condition in which excess fat accumulates within liver cells, impairing normal liver function over time. It is broadly divided into two main types: metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD), and alcohol-related liver disease (ARLD). MASLD is the more prevalent form and is closely linked to obesity, type 2 diabetes, high cholesterol and insulin resistance.

Fatty liver disease is extremely common in the UK. NHS and NICE guidance estimates that MASLD affects up to around one in three adults in the UK to some degree, making it one of the most widespread chronic liver conditions in the country.^[1][4] Many people have no symptoms in the early stages, and the condition is often identified incidentally during routine blood tests or abdominal ultrasound scans.

Without intervention, fatty liver disease can progress through stages of increasing severity. A proportion of people develop metabolic dysfunction-associated steatohepatitis (MASH), characterised by liver inflammation, which can lead to fibrosis (scarring), cirrhosis and, in some cases, liver failure or hepatocellular carcinoma. Early identification and lifestyle modification are therefore central to NICE-aligned management. At the time of writing, no medicine is specifically licensed by the MHRA for the treatment of MASLD in routine UK clinical practice, and NICE has not issued a technology appraisal recommending a pharmacological therapy for MASLD; readers should check current NICE guidance and the MHRA register for any updates.^[2][3]

In UK primary care, initial fibrosis risk stratification typically uses a simple blood-test score such as the FIB-4 index or the NAFLD fibrosis score. People at higher risk may be referred for enhanced liver fibrosis (ELF) testing or specialist assessment, in line with NICE guideline NG49 and BSG/BASL recommendations. Risk factors for MASLD include a high-calorie diet, physical inactivity, central obesity and certain metabolic conditions. Many of these are modifiable, which is why dietary and lifestyle changes, including the potential role of foods such as ginger, are of genuine clinical and public interest.

If you develop any of the following symptoms, contact your GP promptly or call NHS 111: jaundice (yellowing of the skin or whites of the eyes), dark urine or pale stools, unexplained confusion or drowsiness, vomiting blood or passing black tarry stools, or rapidly worsening abdominal swelling. These may indicate serious liver complications requiring urgent assessment. Call 999 or go to your nearest A&E if symptoms are severe or sudden.

Can ginger actually help with a fatty liver?

Ginger is not a licensed treatment for fatty liver disease, but its anti-inflammatory and antioxidant compounds may offer supportive benefits as part of a healthy diet. It should not replace medical care or prescribed treatment.

Ginger (Zingiber officinale) shows promising biological properties that may support liver health, though it is not a treatment for fatty liver disease and should not replace medical care. Ginger contains active compounds, most notably gingerols and shogaols, which have demonstrated anti-inflammatory, antioxidant and lipid-lowering effects in laboratory and animal studies, and in some small human trials.^[5] These mechanisms are relevant because oxidative stress and chronic low-grade inflammation are key drivers of MASLD progression.

In practical terms, ginger is a culinary ingredient with a long history of use in traditional medicine across many cultures. It is widely available in the UK as a fresh root, dried powder, capsule supplement or tea. When consumed in ordinary food quantities, ginger is generally well tolerated by most adults. Common mild side effects, particularly at higher supplement doses, can include heartburn, acid reflux, abdominal discomfort, belching and mouth irritation.

It is important to be clear about what ginger can and cannot do. Ginger is not licensed by the MHRA as a medicine for MASLD, and NICE has not recommended ginger as a treatment for this condition. The evidence base, while encouraging in some respects, remains largely preclinical or based on small human trials. Ginger should therefore be considered a potentially supportive dietary addition within a broader healthy lifestyle, rather than a standalone remedy.

For people seeking structured support for weight management or metabolic health, which are central to managing MASLD, a clinician-led approach is recommended. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, which may be relevant for those whose fatty liver is linked to obesity or metabolic risk factors.

What does the research say about ginger and liver health?

Small trials and a meta-analysis suggest ginger supplementation reduces ALT, AST, cholesterol and triglycerides in people with NAFLD, but evidence is preliminary with no proven benefit on fibrosis or clinical outcomes.

Research into ginger and liver health is growing, though the evidence is not yet sufficient to make firm clinical recommendations. Several small randomised controlled trials have examined the effects of ginger supplementation on liver enzymes, lipid profiles and markers of inflammation in people with NAFLD or MASLD. A number of these studies have reported reductions in alanine aminotransferase (ALT) and aspartate aminotransferase (AST), which are liver enzymes that rise when the liver is inflamed or damaged.

A systematic review and meta-analysis published in the journal Phytotherapy Research found that ginger supplementation was associated with statistically significant reductions in ALT, AST, total cholesterol, triglycerides and fasting blood glucose in people with NAFLD compared with placebo. These are surrogate outcomes, meaning they are measurable markers associated with disease activity rather than direct evidence of benefit on liver histology, fibrosis or clinical events. The trials included in such reviews are typically small, short in duration (often 8 to 12 weeks), and variable in the dose and form of ginger used, which limits the strength of conclusions.^[5] The magnitude of the observed changes and their long-term clinical relevance remain uncertain. No published trials to date have demonstrated a benefit on fibrosis progression or clinical outcomes using histological or MRI-based fat-fraction (MRI-PDFF) endpoints.

Animal studies have provided mechanistic insights, suggesting that gingerols may reduce hepatic fat accumulation, suppress inflammatory cytokines such as TNF-alpha and IL-6, and improve insulin sensitivity.^[5] These findings are biologically plausible but cannot be directly extrapolated to human clinical practice.

Overall, the current evidence is encouraging but preliminary. Larger, well-designed randomised controlled trials with longer follow-up periods and histological or MRI-PDFF endpoints are needed before ginger supplementation can be formally recommended as part of MASLD management. Patients should discuss any supplementation with their GP or hepatologist, particularly if they are taking prescribed medications.

How much ginger is safe to consume if you have liver disease?

Culinary ginger is generally safe; research trials typically use 1 to 3 grams of ginger powder daily. High-dose supplements require caution, especially if you take anticoagulants or have advanced liver disease.

For most adults, consuming ginger in culinary amounts is considered safe and is unlikely to cause harm to the liver. Typical dietary intake, such as adding fresh or dried ginger to cooking, teas or smoothies, generally falls well within amounts that have been used without adverse effects in research studies. Clinical trials in people with NAFLD have typically used doses in the range of 1 to 3 grams of ginger powder per day; some reviews cite up to around 4 grams per day from all sources as a level used in research, though this is not a formal UK clinical guideline and no official upper limit has been established by a UK regulatory body.

For people with existing liver disease, a degree of caution is warranted, particularly with concentrated ginger supplements. Ginger has mild blood-thinning properties, and high-dose supplements may interact with certain medications, including anticoagulants such as warfarin, antiplatelet drugs and some diabetes medications.^[6] This effect may be amplified in people taking prescribed medicines that affect clotting or blood glucose. For UK-specific interaction guidance, the Specialist Pharmacy Service (SPS) and the BNF are useful resources.

It is also worth noting that the liver is responsible for metabolising many compounds, including herbal supplements. In people with advanced liver disease or cirrhosis, the liver's capacity to process supplements may be reduced, making professional guidance especially important.

High-dose ginger supplements are not recommended during pregnancy or breastfeeding unless specifically advised by a clinician. If you are due to have surgery, seek advice from your surgical or anaesthetic team about stopping herbal supplements beforehand, as many centres recommend stopping them one to two weeks before an operation because of a possible effect on bleeding.

Key safety points to discuss with your GP or specialist:

• Inform your doctor of any supplements you are taking, including ginger capsules or extracts

• Avoid high-dose ginger supplements if you are on anticoagulant or antiplatelet therapy without medical advice

• Do not use ginger supplementation as a substitute for prescribed treatment or medical monitoring

• Avoid high-dose ginger supplements during pregnancy or breastfeeding unless a clinician advises otherwise

• Seek advice before surgery about whether to stop herbal supplements in advance

• If you experience new or worsening symptoms such as jaundice, abdominal pain or unexplained fatigue, contact your GP promptly

If you suspect you have experienced a side effect from a herbal supplement or medicine, you can report it to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk. For urgent concerns about liver symptoms, contact your GP or call NHS 111.

What other lifestyle changes support a healthy liver?

NICE NG49 recommends 5 to 10 per cent body weight loss, a Mediterranean-style diet and at least 150 minutes of moderate aerobic activity weekly as the most effective interventions for MASLD.

The most effective interventions for fatty liver disease are sustained lifestyle modifications, particularly weight loss, dietary improvement and increased physical activity. NICE guideline NG49 on MASLD emphasises that even a modest reduction in body weight of 5 to 10 per cent can lead to meaningful improvements in liver fat content and liver enzyme levels.^[1] Greater weight loss of 10 per cent or more is associated with improvements in liver inflammation and fibrosis in some patients, in line with both NICE NG49 and BSG/BASL guidance.^[1]

A balanced, whole-food diet is central to liver health. Evidence supports a Mediterranean-style dietary pattern, which is rich in vegetables, legumes, wholegrains, oily fish, olive oil and nuts, and low in ultra-processed foods, refined sugars and saturated fats. Reducing fructose intake, particularly from sugary drinks and processed foods, is specifically relevant to MASLD because excess fructose is preferentially converted to fat in the liver.

Regular physical activity improves insulin sensitivity and reduces hepatic fat independently of weight loss. UK Chief Medical Officers' guidelines, reflected in NHS guidance, recommend at least 150 minutes of moderate-intensity aerobic activity per week, alongside muscle-strengthening activities on two or more days.^[7][8] Both aerobic exercise and resistance training have shown benefit in MASLD.

Alcohol reduction or abstinence is important even in MASLD, as alcohol adds an additional metabolic burden to an already stressed liver. People with ARLD should seek specialist support for alcohol reduction.

For those who need additional support with weight management, NHS Tier 2 and Tier 3 weight-management services may be available through referral from a GP, though access varies by local Integrated Care Board (ICB) area.

Additional evidence-based measures include:

• Achieving and maintaining a healthy body weight

• Managing blood glucose, blood pressure and cholesterol with GP support

• Avoiding unnecessary over-the-counter medications and supplements that are hepatotoxic

• Attending regular liver function monitoring as advised by your GP or specialist

Ginger can be a useful part of a healthy, anti-inflammatory diet, but it works best alongside, not instead of, these broader lifestyle changes.

Scientific References

1. Non-alcoholic fatty liver disease (NAFLD): assessment and management [NG49].
2. GID-TA11477 Draft scope post-referral: MASLD/MASH.
3. Resmetirom (Rezdiffra) authorised to treat metabolic dysfunction-associated steatohepatitis (MASH) in adults.
4. Non-alcoholic fatty liver disease (NAFLD).
5. Assessment report on Zingiber officinale Roscoe, rhizoma.
6. Interactions of warfarin with garlic, ginger, ginkgo, or ginseng: nature of the evidence.
7. UK Chief Medical Officers' Physical Activity Guidelines.
8. Physical activity guidelines for adults aged 19 to 64.

Frequently Asked Questions